Author

Parvaneh Rahimi‐Moghaddam

Observed names: P Rahimi-Moghaddam, P. RAHIMI-MOGHADDAM, P. Rahimi-Moghaddam, Parvaneh Rahimi-Moghaddam, Parvaneh RAHIMI‐MOGHADDAM, Parvaneh Rahimi Moghaddam, Parvaneh Rahimi-Moghadam, Parvaneh Rahimi-Moghaddam, Parvaneh Rahimi-moghaddam, Rahimi-Moghaddam, Parvaneh
ORCID: 0000-0001-9344-8143
Observed ORCID: 0000-0001-9344-8143
OpenAlex ID: A5083197578
2008 · Massoud Mahmoudian, Parvaneh Rahimi-Moghaddam · Recent Patents on Anti-Cancer Drug Discovery · 142
2007 · Nastaran Heidari, Bahram Goliaei, et al. · Anti-Cancer Drugs · 35
2012 · Zahra Kiani, Massoumeh Shafiei, et al. · Analytica Chimica Acta · 34
2011 · Parvaneh Rahimi-Moghaddam, Soltan Ahmed Ebrahimi, et al. · PubMed Central · 31
2009 · F. Benaissa, H. Mohseni-Rad, et al. · Acta Physiologica Hungarica · 21
2007 · Farideh Sepahvand, Massoumeh Shafiei, et al. · Basic & Clinical Pharmacology & Toxicology · 18
2007 · Farideh Sepahvand, Parvaneh Rahimi-Moghaddam, et al. · Journal of Toxicology and Environmental Health · 18
2006 · N. IZADI MOOD, Z. EFTEKHAR, et al. · International Journal of Gynecological Cancer · 18
2024 · Afrooz Mohammadgholi-Beiki, Mohammad Sheibani, et al. · International Immunopharmacology · 16
2009 · Bahareh Tavakoli-Far, Nahid Rahbar-Roshandel, et al. · European Journal of Pharmacology · 16
2023 · Valentina A. Babenko, Ksenia S. Fedulova, et al. · Journal of Personalized Medicine · 14
2009 · Narges Izadi Mood, Nasrin Samadi, et al. · PubMed Central · 14
2020 · Foad Ghazizadeh, Massoumeh Shafiei, et al. · Evidence-based Complementary and Alternative Medicine · 12
1996 · Aryamanesh, Simin, Seyyed Meisam Ebrahimi, et al. · Europe PMC (PubMed Central) · 11
2024 · Helia Aghamiri, Afrooz Mohammadgholi-Beiki, et al. · Inflammopharmacology · 9
2011 · Fatemeh Namvaran, Parvaneh Rahimi-Moghaddam, et al. · Europe PMC (PubMed Central) · 8
2020 · Elham Ghorbani, Mahsa Mohammadi, et al. · Biochemical Genetics · 6
Works count: 55
Citation count: 1,825
H-index: 15
I10-index: 21
Year
Topic
Type